Author

Evgenia Moschogianni

Emory UniversityORCID 0009-0008-0375-9633Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 1 Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 1 Assay:CRISPR screen· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Antonis AthanasiadisiD· 3 shared Catherine A. FreijeiD· 3 shared Charles M. RiceiD· 3 shared Chenhui Zou· 3 shared Corrine QuirkiD· 3 shared Eleftherios MichailidisiD· 3 shared Georgios DangasiD· 3 shared William M. SchneideriD· 3 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMolecular Biology

Antonis AthanasiadisORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Molecular BiologybioRxivPreprintSep 23, 2026

The HBV basal core promoter mutation confers a replicative advantage and transcriptionally reprograms hepatocytes toward HCC subtypes

Leon Louis Seifert, Georgios Dangas, Hoyin Chu…·Ype P. de Jong

This study shows that HBV BCP mutations enhance viral replication and alter hepatocyte transcription, linking to specific HCC subtypes.

DOI 10.64898/2026.09.22.752323

humanbulk RNA-seq

𝕏 PostBluesky

GenomicsbioRxivPreprintAug 18, 2026

A CRISPR-Cas9 platform for primary human hepatocytes enables arrayed screening and in vivo validation of HBV host factors

Ansgar F. Stenzel, Antonis Athanasiadis, Georgios Dangas…·Eleftherios Michailidis

The paper develops CRISPR-Cas9 delivery methods for primary human hepatocytes to enable efficient gene editing and screening of HBV host factors.

DOI 10.64898/2026.08.10.743996

humanCRISPR screen

𝕏 PostBluesky

MicrobiologybioRxivPreprintJul 24, 2026

Orthogonal CRISPR screens and human liver chimeric mice identify hepatitis B virus host factors

Catherine A. Freije, Georgios Dangas, Antonis Athanasiadis…·Eleftherios Michailidis

The paper identifies HBV host factors using CRISPR screens and human liver chimeric mice, finding that EXOC1 is antiviral and ZCCHC14 is proviral.

DOI 10.64898/2026.07.23.740386

humangenetic perturbation / CRISPR

𝕏 PostBluesky